Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $45.2 Million - $57.1 Million
679,400 Added 180.26%
1,056,300 $88.5 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $15.8 Million - $18.2 Million
-250,000 Reduced 39.88%
376,900 $25.9 Million
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $44.9 Million - $54.7 Million
626,900 New
626,900 $45.9 Million
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $5.56 Million - $6.97 Million
-96,000 Reduced 37.28%
161,500 $9.6 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $39.1 Million - $44.6 Million
-652,200 Reduced 71.69%
257,500 $16.6 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $44.8 Million - $51 Million
-790,300 Reduced 46.49%
909,700 $53 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $2.68 Million - $3.37 Million
-43,200 Reduced 2.48%
1,700,000 $107 Million
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $125 Million - $145 Million
1,727,900 Added 11293.46%
1,743,200 $134 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $2.96 Million - $3.32 Million
-47,400 Reduced 75.6%
15,300 $995,000
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $7.13 Million - $9.31 Million
-117,800 Reduced 65.26%
62,700 $3.92 Million
Q2 2018

Aug 08, 2018

SELL
$64.88 - $75.68 $12.1 Million - $14.1 Million
-186,600 Reduced 50.83%
180,500 $12.8 Million
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $21.5 Million - $26.2 Million
294,600 Added 406.34%
367,100 $27.7 Million
Q4 2017

Feb 09, 2018

SELL
$71.15 - $83.52 $5.64 Million - $6.61 Million
-79,200 Reduced 52.21%
72,500 $5.19 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $10.9 Million - $13 Million
151,700
151,700 $12.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.